2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel
Angelergues, A., Bellmunt, J., Efstathiou, E., Gonzalez, I., Gyftaki, R., Delanoy, N., Ozguroglu, M., Flechon, A., Guillot, A., Le Moulec, S., Castellano, D., Esteban, E., Munarriz, J., Campos Balea,Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31357-0
Date:
September, 2015
File:
PDF, 64 KB
english, 2015